Nimy seeks gallium bounty at Block 3
Potential to outline world class deposit of the semiconductor super metal
Gallium supply is dominated by China, with Nimy already seeing external interest in future product
Special Report: Hot on the heels of what could be a game-changing discovery of semi-conductor super metal gallium, resource drilling has begun at Nimy Resources' Mons project.
The junior explorer's discovery of high-grade gallium in a virtually unexplored greenstone belt north of WA's Wheatbelt could lead to the extraction of a new and strategically valuable source of the critical mineral.
An exploration target reported over the 3km by 1.5km Block 3 prospect by Nimy Resources (ASX:NIM) on January 28 clocked in at 9.6-14.3Mt at 39-78ppm gallium.
The Phase 2 drill campaign is set to take three weeks, with assays due as soon as feasible.
The aim of the program is to extend known high-grade mineralisation along strike and down dip, with the exploration target only encompassing the eastern segment of the Block 3 prospect.
Nimy will drill test the new Block 3 Central target during the program, which will support the development of a maiden JORC resource.
'The commencement of this round of drilling at the Block 3 Gallium discovery is significant as we move forward in defining a world class JORC compliant high grade gallium deposit,' Nimy managing director Luke Hampson said.
'Concurrently, Curtin University are working on metallurgical testing following CSIRO identification of high grade 400-800 g/t gallium in chlorite.
'These exploration milestones move Nimy closer to meeting the need of gallium customers who have made initial enquiries as to our progress.'
Drilling has begun at Nimy's Block 3 gallium prospect. Pic: Nimy
Strategic gallium project
Most gallium is produced by China as a byproduct of alumina and zinc refining, with as much as 98% of the supply chain controlled by the Middle Kingdom, a danger hammered home when it restricted direct exports to the US last year.
Nimy's Block 3 has been shown by initial mineralogical assessments by the CSIRO to contain high grades of 400-800g/t in samples of gallium in chlorite.
Met testwork with Curtin University and its WA School of Mines lab is another critical step, with Nimy already working with M2i Global, a US-based defence and tech solutions company to support a US Department of Defense procurement contract for its gallium.
Gallium is used in semiconductors, EV and wind magnets, solar panels, LEDs, LCDs, blu-rays, with its rise in the world of computer chip wafers resulting from its status as a superior replacement for silicon.
The metal is listed as a critical mineral across Australia, the EU, the UK, the US, India, Japan, and South Korea.
A Phase 3 drill program is expected to follow the Phase 2 program based on the assay results.
Drilling will encompass testing of the new Block 3 Central target. Pic: Nimy
This article was developed in collaboration with Nimy Resources, a Stockhead advertiser at the time of publishing.
This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

News.com.au
23 minutes ago
- News.com.au
Optus sued over 2022 data breach that exposed data of 9.5m people
Optus is being sued for allegedly failing to protect the data of 9.5 million people. The Australian Information Commissioner announced on Friday it was launching the legal action. The case stems from a data breach in September 2022. The Information Commissioner will argue Optus failed to adequately manage cybersecurity and information security risk. 'Organisations hold personal information within legal requirements and based upon trust,' commissioner Elizabeth Tydd said. 'The Australian community should have confidence that organisations will act accordingly, and if they don't, the OAIC as regulator will act to secure those rights.' An Optus spokesperson said the company would 'consider the matters raised in the proceedings and will respond to the claims made by the AIC in due course'. 'Optus apologises again to our customers and the broader community that the 2022 cyber attack occurred,' the spokesperson said. 'We strive every day to protect our customers' information and have been working hard to minimise any impact the cyber attack may have had.' Optus would keep investing in security, the spokesperson said, and the cyber threat environment was evolving. 'As the matter is now before the Australian courts, Optus will not be commenting further at this time,' they said. Australian Privacy Commissioner Carly Kind said strong data governance and security needed to be embedded in organisations. 'To guard against vulnerabilities that threat actors will be ready to exploit,' Ms Kind said. The lawsuit alleges that from on, or around October 17, 2019 to September 20, 2022, Optus seriously interfered with the privacy of about 9.5 million Australians by failing to take reasonable steps to protect their personal information from misuse, interference and loss, and from unauthorised access, modification or disclosure. The case is being pursued as an alleged breach of the Privacy Act 1988. The Information Commission alleges Optus failed to adequately manage cybersecurity and information security risk in a manner commensurate with the nature and volume of personal information that Optus held, the company's size and its risk profile.

News.com.au
an hour ago
- News.com.au
Labor vows to ‘fight' as Trump threatens pharma tariffs
The Albanese government is vowing to 'fight for the PBS' as Donald Trump tries to strongarm drugmakers into moving production to the US. The Pharmaceutical Benefits Scheme (PBS) is a list of federally subsidised medicines and a prized Labor invention. Health Minister Mark Butler last month introduced legislation that, if passed, would cap PBS-listed medicines at $25 from January 1, 2026. Aside from subsidising medicines, the scheme also compels firms to negotiate prices with the federal government, which helps keep products affordable. Celebrated as a cornerstone of the healthcare system in Canberra, the scheme is denounced by pharmaceutical lobbyists in Washington, who claim Australia is 'freeloading on American innovation'. One group, Pharmaceutical Research and Manufacturers of America (PhRMA), has explicitly urged the Trump administration to 'leverage ongoing trade negotiations' to influence Australia's PBS policies. But Anthony Albanese, Mr Butler and other ministers have ruled out budging on the PBS. 'We'll fight for our PBS and fight for the jobs of Australian manufacturers here,' Mr Butler told the ABC on Friday, noting most production is in Melbourne. Pharmaceutical exports to the US totalled north of $2bn in 2024, making it the biggest foreign market for Australian producers. Exports are mostly blood products and vaccines but also include packaged medicines and miscellaneous medical items, such as bandages. Though, as Mr Butler noted, the US still exported more to Australia and did so without tariffs. 'We have zero tariffs on those imports that we take from America companies,' he said. 'We're making the case that should continue in reverse. 'We should be able to continue to export our terrific blood and plasma products and medicines to Americans without what might be a 250 per cent tariff.' For the moment, Mr Trump's concern with the sector appears to be largely driven by bringing down prices in the US rather than punishing allies for having cheaper medicines. Last week, he wrote to 17 major pharmaceutical companies demanding they lower their prices for American consumers to bring them in line with prices overseas. A Rand Corporation report found that Americans pay nearly four times more than Australians for medicines and about three times more than the average in other developed economies. The answer, according to Mr Trump, is making pharmaceuticals in the US. Mr Trump's 250 per cent tariff threat was a warning shot to firms, but one that, if realised, would hit producers Down Under hard.

News.com.au
an hour ago
- News.com.au
Zeekr 7X Australia specs and price revealed
Chinese EV maker Zeekr has announced a bold move that could undermine Tesla's hold on the Australian market. Many vehicles in Australia are capable of ultra-fast charging; however, their ability is limited in practice due to underdeveloped EV infrastructure. Yes, Tesla does offer Superchargers, but this infrastructure is often exclusive to Tesla owners. For other EV drivers, there are limited public EVs that support truly rapid charging. In New South Wales, if you exclude Tesla-exclusive chargers, there are approximately a dozen stations capable of 350kWh or higher charging that are available to the public. Currently, there are 93,078 registered electric vehicles in the State, according to Transport NSW. This equates to thousands of electric vehicles for every 350kW charger in New South Wales. Zeekr views this as an opportunity to bring their ultra-fast 800V charging stations to Australia, which has already seen immense success in China. Zeekr Vice President Frank Li says the company is 'seriously considering' building a network of ultra-fast chargers around Australia to accommodate the growing need of their customers. 'We're seriously considering this to support our 800V vehicles. Fast, reliable charging is essential to the Zeekr experience, and we're working on solutions that deliver real value to our customers,' Mr Li says. The company plans to launch a massive charging network as part of its ambitious strategy for the Australian market, following the recent introduction of the Zeekr 7X, which is the company's first vehicle to feature an 800V platform in Australia. Zeekr's mid-sized SUV competes directly with other popular models, such as the Tesla Model Y, BYD Sealion 7, and various other electric SUVs. The 2025 Zeekr 7X starts at $57,900 before on-road costs (around $64,000 drive-away), with the flagship Performance AWD variant priced at $72,900. That positions the 7X about $1000 cheaper than the Tesla Model Y, though slightly more expensive than the BYD Sealion 7. Zeekr says the price for the 7X, which joins the Zeekr X (a small SUV) and the Zeekr 009 (a luxury people mover) in the brand's expanding Australian line-up, remains competitive in the country's growing market. 'This was intended to bring the Zeekr brand to more Australian homes. With so much to offer, we really feel this is incredible value,' Mr Li said. 'We justify our price positioning by delivering long-term value and a tech-forward ownership experience tailored to discerning Australian drivers.' The 7X range comprises three main variants: the RWD (standard range), RWD long-range, and 7X Performance AWD. All variants will support Zeekr's 'Golden Battery' technology, which enables rapid charging from 10 per cent to 80 per cent in just 13 minutes. The RWD model features a 75kWh LFP battery and comes standard with height-adjustable air suspension, heated front seats, 19-inch alloy wheels, a panoramic sunroof (with electric sunshade), and interior ambient lighting. According to the EV brand, this variant is capable of a claimed 0-100km/h sprint in around 6.0 seconds. Next in line is the 7X RWD long-range model, which features similar characteristics to the RWD model but offers a larger 100 kWh battery. Despite the increased battery capacity, performance remains unchanged compared to the standard RWD model. The top-spec model of the Zeekr 7X range is the Performance AWD, which delivers the best performance figures in the line-up and shares its battery with the Long Range RWD variant. It is equipped with the same 100 kWh battery found in the long-range model but uses twin electric motors, enabling a 0-100 km/h acceleration in just 3.8 seconds. The EV brand aims to sell over 2,000 electric vehicles in 2025, and according to Melvyn Low, Zeekr's Head of Product, the 7X plays a crucial role in the brand's achievement of this milestone. 'Our insights into Australian consumers reveal a strong appetite for EVs that combine practicality, performance, and premium design — without the compromises often seen in legacy models,' Melvyn said. 'The 7X reflects this understanding, offering a purpose-built electric SUV tailored to local driving conditions and lifestyle needs, with the space, tech, and refinement modern drivers expect. 'With performance at its core and continuous evolution through OTA updates, the 7X redefines what it means to drive premium.'